Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

3.99
Delayed Data
As of Jun 23
 +0.02 / +0.50%
Today’s Change
2.35
Today|||52-Week Range
5.75
+44.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues5.9M5.2M7.0M5.2M
 
 
 
 
 
Cost of Goods Sold1.7M1.3M1.9M1.6M
 
 
 
 
 
Depreciation And Amortization750.0K853.0K853.0K835.0K
 
 
 
 
 
 
Operating ExpensesGross Income3.5M3.0M4.3M2.7M
 
 
 
 
 
General Expenses8.0M7.2M9.1M8.2M
 
 
 
 
 
Total Operating Expenses10.4M9.4M11.8M10.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.5M-4.1M-4.8M-5.5M
 
 
 
 
 
Extraordinary Charge-1.4M0.000.000.00
 
 
Interest Expense On Debt445.0K865.0K828.0K787.0K
 
 
 
 
 
Other Expenses-1.1M-203.0K-41.0K-11.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.4M-5.2M-5.7M-6.3M
 
 
 
 
 
Income Taxes-94.0K-88.0K-73.0K-43.0K
 
 
 
 
 
Net Income-7.5M-5.3M-5.6M-6.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.4M28.4M31.9M31.9M
 
 
 
 
 
Shares To Calculate EPS Diluted20.4M28.4M31.9M31.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.37-$0.19-$0.18-$0.20
 
 
 
 
 
EPS Diluted-$0.37-$0.19-$0.18-$0.20